Log in to save to my catalogue

Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL

Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10236623

Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL

Publication information

Publisher

England: John Wiley & Sons, Inc

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10236623

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10236623

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.15784

How to access this item